Differential and synergistic effects of mechanical stimulation and growth factor presentation on vascular wall function

Biomaterials

Volumn 34, Issue 30, 2013, Pages 7281-7291

  Liang, Mao Shih ^a   Koobatian, Maxwell ^c   Lei, Pedro ^a   Swartz, Daniel D ^c   Andreadis, Stelios T ^a,b,c  

^a the State University of New York   (United States)

^b University at Buffalo The State University of New York   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Fibrin hydrogels; Growth factor presentation; Mechanical stimulation; Vascular contractility; Vascular tissue engineering

Indexed keywords

BIOMIMETIC APPROACHES; CARDIAC REGENERATION; GROWTH FACTOR; MECHANICAL STIMULATION; MYOGENIC DIFFERENTIATIONS; TISSUE ENGINEERING APPLICATIONS; VASCULAR CONTRACTILITY; VASCULAR TISSUE ENGINEERING;

BIOMIMETICS; MECHANICAL PROPERTIES; TISSUE ENGINEERING;

HYDROGELS;

BLOOD CLOTTING FACTOR 13; FIBRIN; SILASTIC; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BIOMIMETICS; BIOREACTOR; BLOOD VESSEL GRAFT; BLOOD VESSEL REACTIVITY; BLOOD VESSEL WALL; CONTROLLED STUDY; CULTURE MEDIUM; FIBRIN POLYMERIZATION; HUMAN; HUMAN TISSUE; HYDROGEL; MECHANICAL STIMULATION; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; SECRETION (PROCESS); TISSUE DIFFERENTIATION;

FIBRIN HYDROGELS; GROWTH FACTOR PRESENTATION; MECHANICAL STIMULATION; VASCULAR CONTRACTILITY; VASCULAR TISSUE ENGINEERING;

BLOOD VESSEL PROSTHESIS; BLOOD VESSELS; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; IMMOBILIZED PROTEINS; INFANT, NEWBORN; MALE; MYOSIN HEAVY CHAINS; STRESS, MECHANICAL; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84880506141     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.05.073     Document Type: Article

References (70)

1. Niklason L.E., Abbott W., Gao J., Klagges B., Hirschi K.K., Ulubayram K., et al. Morphologic and mechanical characteristics of engineered bovine arteries. JVasc Surg 2001, 33:628-638.
2. Niklason L.E., Gao J., Abbott W.M., Hirschi K.K., Houser S., Marini R., et al. Functional arteries grown invitro. Science 1999, 284:489-493.
3. Wu W., Allen R.A., Wang Y. Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoartery. Nat Med 2012, 18:1148-1153.
4. Stegemann J.P., Hong H., Nerem R.M. Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype. JAppl Physiol 2005, 98:2321-2327.
5. Stegemann J.P., Nerem R.M. Phenotype modulation in vascular tissue engineering using biochemical and mechanical stimulation. Ann Biomed Eng 2003, 31:391-402.
6. Syedain Z.H., Weinberg J.S., Tranquillo R.T. Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue. Proc Natl Acad Sci U S A 2008, 105:6537-6542.
7. Isenberg B.C., Tranquillo R.T. Long-term cyclic distention enhances the mechanical properties of collagen-based media-equivalents. Ann Biomed Eng 2003, 31:937-949.
8. Syedain Z.H., Meier L.A., Bjork J.W., Lee A., Tranquillo R.T. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials 2011, 32:714-722.
9. Liu J.Y., Swartz D.D., Peng H.F., Gugino S.F., Russell J.A., Andreadis S.T. Functional tissue-engineered blood vessels from bone marrow progenitor cells. Cardiovasc Res 2007, 75:618-628.
10. Yao L., Swartz D.D., Gugino S.F., Russell J.A., Andreadis S.T. Fibrin-based tissue-engineered blood vessels: differential effects of biomaterial and culture parameters on mechanical strength and vascular reactivity. Tissue Eng 2005, 11:991-1003.
11. Swartz D.D., Russell J.A., Andreadis S.T. Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am J Physiol Heart Circ Physiol 2005, 288:H1451-H1460.
12. Peng H., Schlaich E.M., Row S., Andreadis S.T., Swartz D.D. Anovel ovine exvivo arteriovenous shunt model to test vascular implementability. Cells Tissues Organs 2012, 195:108-121.
13. Peng H.F., Liu J.Y., Andreadis S.T., Swartz D.D. Hair follicle-derived smooth muscle cells and small intestinal submucosa for engineering mechanically robust and vasoreactive vascular media. Tissue Eng Part A 2011, 17:981-990.
14. L'Heureux N., Paquet S., Labbe R., Germain L., Auger F.A. Acompletely biological tissue-engineered human blood vessel. FASEB J 1998, 12:47-56.
15. L'Heureux N., Stoclet J.C., Auger F.A., Lagaud G.J., Germain L., Andriantsitohaina R. Ahuman tissue-engineered vascular media: a new model for pharmacological studies of contractile responses. FASEB J 2001, 15:515-524.
16. Neidert M.R., Lee E.S., Oegema T.R., Tranquillo R.T. Enhanced fibrin remodeling invitro with TGF-beta1, insulin and plasmin for improved tissue-equivalents. Biomaterials 2002, 23:3717-3731.
17. Wanjare M., Kuo F., Gerecht S. Derivation and maturation of synthetic and contractile vascular smooth muscle cells from human pluripotent stem cells. Cardiovasc Res 2012.
18. Gacchina C.E., Ramamurthi A. Impact of pre-existing elastic matrix on TGFbeta1 and HA oligomer-induced regenerative elastin repair by rat aortic smooth muscle cells. JTissue Eng Regen Med 2011, 5:85-96.
19. Liang M.S., Andreadis S.T. Engineering fibrin-binding TGF-beta1 for sustained signaling and contractile function of MSC based vascular constructs. Biomaterials 2011, 32:8684-8693.
20. Zhang G., Suggs L.J. Matrices and scaffolds for drug delivery in vascular tissue engineering. Adv Drug Deliv Rev 2007, 59:360-373.
21. Arayne M.S., Sultana N. Porous nanoparticles in drug delivery systems. Pak J Pharm Sci 2006, 19:158-169.
22. Zhang G., Drinnan C.T., Geuss L.R., Suggs L.J. Vascular differentiation of bone marrow stem cells is directed by a tunable three-dimensional matrix. Acta Biomater 2010, 6:3395-3403.
23. Grouf J.L., Throm A.M., Balestrini J.L., Bush K.A., Billiar K.L. Differential effects of EGF and TGF-beta1 on fibroblast activity in fibrin-based tissue equivalents. Tissue Eng 2007, 13:799-807.
24. Goncalves L.M., Epstein S.E., Piek J.J. Controlling collateral development: the difficult task of mimicking mother nature. Cardiovasc Res 2001, 49:495-496.
25. Han J., Liu J.Y., Swartz D.D., Andreadis S.T. Molecular and functional effects of organismal ageing on smooth muscle cells derived from bone marrow mesenchymal stem cells. Cardiovasc Res 2010, 87:147-155.
26. Yao L., Liu J., Andreadis S.T. Composite fibrin scaffolds increase mechanical strength and preserve contractility of tissue engineered blood vessels. Pharm Res 2008, 25:1212-1221.
27. Liu J.Y., Peng H.F., Andreadis S.T. Contractile smooth muscle cells derived from hair-follicle stem cells. Cardiovasc Res 2008, 79:24-33.
28. Howard J., Grill S.W., Bois J.S. Turing's next steps: the mechanochemical basis of morphogenesis. Nat Rev Mol Cell Biol 2011, 12:392-398.
29. Lu D., Kassab G.S. Role of shear stress and stretch in vascular mechanobiology. JR Soc Interface 2011, 8:1379-1385.
30. Gassman A.A., Kuprys T., Ucuzian A.A., Brey E., Matsumura A., Pang Y., et al. Three-dimensional 10% cyclic strain reduces bovine aortic endothelial cell angiogenic sprout length and augments tubulogenesis in tubular fibrin hydrogels. JTissue Eng Regen Med 2011, 5:375-383.
31. Niklason L.E., Yeh A.T., Calle E.A., Bai Y., Valentin A., Humphrey J.D. Enabling tools for engineering collagenous tissues integrating bioreactors, intravital imaging, and biomechanical modeling. Proc Natl Acad Sci U S A 2010, 107:3335-3339.
32. Schutte S.C., Chen Z., Brockbank K.G., Nerem R.M. Cyclic strain improves strength and function of a collagen-based tissue-engineered vascular media. Tissue Eng Part A 2010, 16:3149-3157.
33. Wang C., Cen L., Yin S., Liu Q., Liu W., Cao Y., et al. Asmall diameter elastic blood vessel wall prepared under pulsatile conditions from polyglycolic acid mesh and smooth muscle cells differentiated from adipose-derived stem cells. Biomaterials 2010, 31:621-630.
34. Xu Z.C., Zhang W.J., Li H., Cui L., Cen L., Zhou G.D., et al. Engineering of an elastic large muscular vessel wall with pulsatile stimulation in bioreactor. Biomaterials 2008, 29:1464-1472.
35. Seliktar D., Nerem R.M., Galis Z.S. Mechanical strain-stimulated remodeling of tissue-engineered blood vessel constructs. Tissue Eng 2003, 9:657-666.
36. Kim B.S., Nikolovski J., Bonadio J., Mooney D.J. Cyclic mechanical strain regulates the development of engineered smooth muscle tissue. Nat Biotechnol 1999, 17:979-983.
37. Kobayashi N., Yasu T., Ueba H., Sata M., Hashimoto S., Kuroki M., et al. Mechanical stress promotes the expression of smooth muscle-like properties in marrow stromal cells. Exp Hematol 2004, 32:1238-1245.
38. Khayat G., Rosenzweig D.H., Quinn T.M. Low frequency mechanical stimulation inhibits adipogenic differentiation of C3H10T1/2 mesenchymal stem cells. Differentiation 2012, 83:179-184.
39. Nikolovski J., Kim B.S., Mooney D.J. Cyclic strain inhibits switching of smooth muscle cells to an osteoblast-like phenotype. FASEB J 2003, 17:455-457.
40. Han J., Mistriotis P., Lei P., Wang D., Liu S., Andreadis S.T. Nanog reverses the effects of organismal aging on mesenchymal stem cell proliferation and myogenic differentiation potential. Stem Cells 2012, 30:2746-2759.
41. Liu J.Y., Peng H.F., Gopinath S., Tian J., Andreadis S.T. Derivation of functional smooth muscle cells from multipotent human hair follicle mesenchymal stem cells. Tissue Eng Part A 2010, 16:2553-2564.
42. Bajpai V.K., Mistriotis P., Loh Y.H., Daley G.Q., Andreadis S.T. Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates. Cardiovasc Res 2012, 96:391-400.
43. Stegemann H., Stalder K. Determination of hydroxyproline. Clin Chim Acta 1967, 18:267-273.
44. Neuman R.E., Logan M.A. The determination of hydroxyproline. JBiol Chem 1950, 184:299-306.
45. Bajpai V.K., Mistriotis P., Andreadis S.T. Clonal multipotency and effect of long-term invitro expansion on differentiation potential of human hair follicle derived mesenchymal stem cells. Stem Cell Res 2012, 8:74-84.
46. Vara D.S., Punshon G., Sales K.M., Hamilton G., Seifalian A.M. Haemodynamic regulation of gene expression in vascular tissue engineering. Curr Vasc Pharmacol 2011, 9:167-187.
47. Hinz B., Dugina V., Ballestrem C., Wehrle-Haller B., Chaponnier C. Alpha-smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts. Mol Biol Cell 2003, 14:2508-2519.
48. Seliktar D., Black R.A., Vito R.P., Nerem R.M. Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling invitro. Ann Biomed Eng 2000, 28:351-362.
49. Gosline J., Lillie M., Carrington E., Guerette P., Ortlepp C., Savage K. Elastic proteins: biological roles and mechanical properties. Philos Trans R Soc Lond B Biol Sci 2002, 357:121-132.
50. Shoulders M.D., Raines R.T. Collagen structure and stability. Annu Rev Biochem 2009, 78:929-958.
51. Grassl E.D., Oegema T.R., Tranquillo R.T. Afibrin-based arterial media equivalent. JBiomed Mater Res A 2003, 66:550-561.
52. Bannasch H., Unterberg T., Fohn M., Weyand B., Horch R.E., Stark G.B. Cultured keratinocytes in fibrin with decellularised dermis close porcine full-thickness wounds in a single step. Burns 2008, 34:1015-1021.
53. Geer D.J., Andreadis S.T. Anovel role of fibrin in epidermal healing: plasminogen-mediated migration and selective detachment of differentiated keratinocytes. JInvest Dermatol 2003, 121:1210-1216.
54. Padmashali R.M., Andreadis S.T. Engineering fibrinogen-binding VSV-G envelope for spatially- and cell-controlled lentivirus delivery through fibrin hydrogels. Biomaterials 2011, 32:3330-3339.
55. Raut S.D., Lei P., Padmashali R.M., Andreadis S.T. Fibrin-mediated lentivirus gene transfer: implications for lentivirus microarrays. JControl Release 2010, 144:213-220.
56. Lei P., Padmashali R.M., Andreadis S.T. Cell-controlled and spatially arrayed gene delivery from fibrin hydrogels. Biomaterials 2009, 30:3790-3799.
57. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004, 84:767-801.
58. Hyytiainen M., Penttinen C., Keski-Oja J. Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 2004, 41:233-264.
59. Riehl B.D., Park J.H., Kwon I.K., Lim J.Y. Mechanical stretching for tissue engineering: two-dimensional and three-dimensional constructs. Tissue Eng Part B Rev 2012, 18:288-300.
60. Clarke D.C., Brown M.L., Erickson R.A., Shi Y., Liu X. Transforming growth factor beta depletion is the primary determinant of Smad signaling kinetics. Mol Cell Biol 2009, 29:2443-2455.
61. Cummings C.L., Gawlitta D., Nerem R.M., Stegemann J.P. Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures. Biomaterials 2004, 25:3699-3706.
62. Solan A., Mitchell S., Moses M., Niklason L. Effect of pulse rate on collagen deposition in the tissue-engineered blood vessel. Tissue Eng 2003, 9:579-586.
63. Rowe S.L., Stegemann J.P. Interpenetrating collagen-fibrin composite matrices with varying protein contents and ratios. Biomacromolecules 2006, 7:2942-2948.
64. Shi-wen X., Kennedy L., Renzoni E.A., Bou-Gharios G., du Bois R.M., Black C.M., et al. Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts. Arthritis Rheum 2007, 56:4189-4194.
65. Shi-Wen X., Rodriguez-Pascual F., Lamas S., Holmes A., Howat S., Pearson J.D., et al. Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors. Mol Cell Biol 2006, 26:5518-5527.
66. Kahari V.M., Olsen D.R., Rhudy R.W., Carrillo P., Chen Y.Q., Uitto J. Transforming growth factor-beta up-regulates elastin gene expression in human skin fibroblasts. Evidence for post-transcriptional modulation. Lab Invest 1992, 66:580-588.
67. Zhang M.C., Giro M., Quaglino D., Davidson J.M. Transforming growth factor-beta reverses a posttranscriptional defect in elastin synthesis in a cutis laxa skin fibroblast strain. JClin Invest 1995, 95:986-994.
68. Kucich U., Rosenbloom J.C., Abrams W.R., Bashir M.M., Rosenbloom J. Stabilization of elastin mRNA by TGF-beta: initial characterization of signaling pathway. Am J Respir Cell Mol Biol 1997, 17:10-16.
69. Kucich U., Rosenbloom J.C., Abrams W.R., Rosenbloom J. Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta, and p38. Am J Respir Cell Mol Biol 2002, 26:183-188.
70. Hong H.H., Uzel M.I., Duan C., Sheff M.C., Trackman P.C. Regulation of lysyl oxidase, collagen, and connective tissue growth factor by TGF-beta1 and detection in human gingiva. Lab Invest 1999, 79:1655-1667.